High-dose cytarabine does not overcome the adverse...

Blood 2015 / 07 Vol. 126; Iss. 5

High-dose cytarabine does not overcome the adverse prognostic value of CDKN2A and TP53 deletions in mantle cell lymphoma

Delfau-Larue, M.-H., Klapper, W., Berger, F., Jardin, F., Briere, J., Salles, G., Casasnovas, O., Feugier, P., Haioun, C., Ribrag, V., Thieblemont, C., Unterhalt, M., Dreyling, M., Macintyre, E., Pott
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
126
Language:
english
Journal:
Blood
DOI:
10.1182/blood-2015-02-628792
Date:
July, 2015
File:
PDF, 498 KB
english, 2015
Conversion to is in progress
Conversion to is failed